Stay updated on Nivolumab Plus SBRT in Metastatic RCC Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Plus SBRT in Metastatic RCC Clinical Trial page.

Latest updates to the Nivolumab Plus SBRT in Metastatic RCC Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe footer’s site revision changed from v3.7.0 to v3.7.1. The page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedThe page now shows a 403 Forbidden error replacing the study record content, with a standard site header/footer and no trial details visible.SummaryDifference17%

- Check31 days agoChange DetectedThe page now shows Revision: v3.7.0, replacing the previous v3.6.6. This reflects a new version of the page's documentation rather than a substantive change to the study data or details.SummaryDifference0.1%

- Check45 days agoChange DetectedThe page now displays the revision label v3.6.6, replacing the previous v3.6.5.SummaryDifference0.1%

- Check66 days agoChange DetectedRevision tag on the page updated from v3.6.4 to v3.6.5, signaling a new internal revision of the Study Details page. No changes to study data, eligibility criteria, or results are indicated by this update.SummaryDifference0.1%

- Check80 days agoChange DetectedThe page revision was updated from v3.6.3 to v3.6.4, indicating a newer version of the study record on ClinicalTrials.gov. This update appears to be a metadata/version-control change rather than a modification to the study content.SummaryDifference0.1%

Stay in the know with updates to Nivolumab Plus SBRT in Metastatic RCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Plus SBRT in Metastatic RCC Clinical Trial page.